New Research from Oregon State University Links Frequent Cannabis Use to Elevated Morning Cortisol Levels and Altered Stress Rhythms

The physiological impacts of frequent cannabis consumption on the human body have become the focus of a growing body of scientific inquiry, particularly as societal acceptance and legislative liberalization drive up usage rates across the United States. Recent findings published in the academic journal Cannabis by researchers at Oregon State University (OSU) indicate that individuals who engage in regular cannabis use may begin their days with significantly higher baseline levels of cortisol—commonly known as the body’s primary stress hormone—compared to non-users. This discovery sheds new light on the complex relationship between chronic cannabinoid exposure and the neuroendocrine systems responsible for managing human stress responses.

Led by Anita Cservenka, an associate professor in the OSU College of Liberal Arts, alongside colleagues Julia Donner and Alexia Obrochta, the investigation specifically examined the hypothalamic-pituitary-adrenal (HPA) axis. This major neuroendocrine system acts as the central command center for the body’s reaction to stress, regulating numerous physiological processes through the release of hormones. While stress relief remains one of the most frequently cited reasons individuals consume cannabis, the scientific community has grown increasingly concerned that long-term, heavy usage patterns might inadvertently interfere with the biological feedback loops designed to keep the human stress response balanced.

Shifting Demographics and Rising Cannabis Consumption Patterns

The release of these physiological findings coincides with a profound transformation in American substance use demographics. Over the past fifteen years, sociological and public health data have documented a sharp, sustained escalation in cannabis consumption, particularly among young adults. Recent epidemiological evaluations reveal that approximately 29 percent of adults aged 19 to 30 report using cannabis within any given 30-day period. This current prevalence rate represents a near-doubling of the frequency observed among the same demographic cohort a decade and a half ago.

Perhaps more critically for researchers monitoring potential health consequences, high-frequency use has also surged. Public health metrics indicate that more than 10 percent of individuals within this young adult age bracket now report consuming cannabis on 20 or more days within a standard 30-day window. This high-frequency usage rate is more than double the figures recorded fifteen years prior. As millions of Americans incorporate frequent cannabis use into their daily routines, toxicologists, neuroscientists, and public health officials face an urgent imperative to understand the long-term biological ramifications of chronic exposure to phytocannabinoids on vital homeostatic systems.

Understanding the Cortisol Awakening Response

To evaluate the interface between cannabis use and the human stress apparatus, the Oregon State University research team centered their methodology on a well-established physiological metric known as the Cortisol Awakening Response (CAR). CAR describes the distinct, predictable surge in cortisol production that healthy human bodies undergo immediately following sleep, typically peaking approximately thirty minutes after a person wakes up.

Calculating CAR requires a precise dual-sampling protocol: researchers collect an initial saliva or blood sample immediately upon waking, followed by a secondary sample exactly thirty minutes later. Subtracting the baseline morning measurement from the thirty-minute post-awakening measurement yields a numerical value that reflects how effectively the endocrine system prepares the body to manage the upcoming demands, cognitive loads, and environmental stressors of the day.

In analyzing the data collected from both frequent cannabis users and non-users, Cservenka and her team noted that the magnitude of the post-awakening cortisol rise—the CAR itself—did not exhibit statistically significant differences between the two cohorts. Both groups experienced a relative spike in hormone levels during the first half-hour of the day. However, a profound divergence emerged at the starting point of the curve. Individuals who engaged in frequent cannabis use demonstrated elevated baseline cortisol concentrations at the exact moment of awakening, meaning their circulating hormone levels were already running higher before the daily CAR spike even occurred.

Physiological Functions and Implications of Cortisol

Cortisol is a steroid hormone synthesized and secreted by the adrenal glands, which sit atop the kidneys. Functioning as a critical chemical messenger, it governs a wide array of metabolic, immunological, and cardiovascular functions. Beyond its colloquial designation as the "stress hormone," cortisol plays an indispensable role in maintaining systemic homeostasis. It regulates blood pressure levels, supports immune system responses by suppressing unnecessary inflammation, and manages blood sugar metabolism to ensure that vital organs receive adequate energy during periods of physical or psychological pressure.

Under normal physiological conditions, short-term elevations in cortisol serve an adaptive purpose, mobilizing internal resources to navigate acute crises or demanding tasks. However, when baseline hormone levels remain chronically elevated over extended periods, the physiological consequences can become detrimental. Persistently high cortisol is clinically associated with an increased vulnerability to mood disorders, including generalized anxiety and clinical depression, as well as heightened risks for cardiovascular disease, metabolic syndrome, and cognitive impairment.

Given these well-documented systemic risks, the discovery that frequent cannabis users exhibit higher waking cortisol levels introduces a vital new dimension to the medical evaluation of chronic cannabis consumption.

Methodological Nuances and Divergent Scientific Literature

The relationship between cannabis use and the human endocrine system has long proved contentious within the broader scientific community, characterized by varying and sometimes contradictory findings across different clinical trials. Cservenka points out that her team’s observations regarding baseline morning cortisol diverge from certain prior studies conducted by other research groups, which previously reported a blunted or diminished CAR among chronic cannabis consumers.

This discrepancy highlights the intricate complexity governing neuroendocrine responses to psychoactive substances. Variations in study populations, demographic variables, frequency definitions, and analytical methodologies can significantly influence cortisol outcomes. For instance, differences in the timing of last use, the chemical potency of the cannabis consumed, and the presence of underlying psychological co-morbidities—such as trauma history or chronic anxiety—frequently confound endocrine evaluations.

Cservenka emphasizes that while the Oregon State University study establishes a clear statistical correlation between frequent use and higher morning cortisol concentrations, it does not definitively prove causation. The data cannot currently determine whether chronic cannabis consumption actively drives up waking cortisol levels, or conversely, whether individuals possessing naturally higher morning stress hormone levels are inherently more prone to developing frequent cannabis use habits as a form of self-medication. Establishing a definitive cause-and-effect pathway will require longitudinal tracking studies that follow cohorts of individuals over extended periods.

Broader Public Health Implications and Future Research Directions

As legalization measures expand across state jurisdictions and commercial markets introduce increasingly potent cannabis formulations—ranging from high-THC flower to concentrated extracts and edibles—the need for comprehensive toxicological and endocrine research becomes increasingly critical. The OSU findings suggest that morning cortisol levels could potentially serve as a novel neurobiological marker for identifying problematic or high-risk cannabis use patterns.

Public health advocates and addiction medicine specialists note that disruptions in normal daily stress rhythms can easily establish a self-perpetuating feedback loop. If chronic cannabis use alters the biological systems responsible for stress regulation, individuals may experience heightened baseline tension or somatic distress when sober, which in turn reinforces the psychological impulse to consume more cannabis for temporary relief. Breaking this cycle requires a sophisticated understanding of both the psychological drivers and the underlying neurobiological alterations associated with chronic use.

Funding for the study was provided by Oregon State University, the OSU Center for the Humanities, and the OSU College of Liberal Arts, reflecting an institutional commitment to advancing empirical knowledge surrounding human health and substance use. As researchers prepare subsequent phases of investigation, the scientific community anticipates that larger, longitudinal studies will help clarify the precise biological mechanisms linking cannabinoid exposure to endocrine function. In the interim, these findings offer clinicians, policymakers, and consumers valuable insight into the subtle, systemic physiological shifts that accompany frequent cannabis consumption.